GREGORY T LUCIER
CIK 1251299 · Chairman & CEO · last filed 2026-06-10
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$3.46M
Companies
11
Total Filings
194
Lifetime Open-Market Net
-$52.36M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| MRVI | Director | 311,200 | $4.98 | $1.55M | $773.5K | 12 | 2026-06-10 |
| XRAY | Director | 101,665 | $10.09 | $1.03M | $2.61M | 47 | 2026-06-05 |
| AVTR | Director | 94,006 | $9.39 | $882.7K | $541.2K | 3 | 2026-05-11 |
| Catalent, Inc. (CTLT) Delisted | Director | 0 | $63.48 | $0 | -$2.49M | 18 | 2024-12-18 |
| Bruker Cellular Analysis, Inc. (CELL) Delisted | Director | 0 | $1.00 | $0 | $0 | 2 | 2023-10-03 |
| Bruker Cellular Analysis, Inc. (BLI) Delisted | Director | 477,051 | $1.20 | $572.5K | $1.47M | 9 | 2022-08-01 |
| NUVASIVE INC (NUVA) Delisted | Director | 266,251 | $39.75 | $10.58M | $1.82M | 31 | 2021-05-20 |
| Invuity, Inc. (IVTY) Delisted | Director | 0 | — | — | $594.1K | 12 | 2018-10-23 |
| CAREFUSION Corp (CFN) Delisted | Director | 34,103 | — | — | $0 | 9 | 2014-11-06 |
| LIFE | Chief Executive Officer | 0 | $15.61 | $0 | -$16.85M | 25 | 2014-02-04 |
| Life Technologies Corp (IVGN) Delisted | CEO | 191,910 | — | — | -$40.82M | 25 | 2008-11-18 |
Recent Filings · Page 7 of 20
194 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-06-01 | XRAY | Grant (A) | +3,008 | $0 | EDGAR |
| 2021-05-20 | NUVASIVE INC (NUVA) Delisted | Mixed | +10,720 | -$591.2K | EDGAR |
| 2021-05-18 | Bruker Cellular Analysis, Inc. (BLI) Delisted | Grant (A) | +1,400 | $0 | EDGAR |
| 2021-05-04 | NUVASIVE INC (NUVA) Delisted | Mixed | +25,851 | -$1.19M | EDGAR |
| 2021-04-12 | XRAY | Grant (A) | +7 | $0 | EDGAR |
| 2021-03-05 | XRAY | Buy (P) | +9,000 | $528.8K | EDGAR |
| 2021-03-04 | XRAY | Buy (P) | +5,000 | $294.8K | EDGAR |
| 2021-02-12 | NUVASIVE INC (NUVA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-01-12 | XRAY | Grant (A) | +9 | $0 | EDGAR |
| 2020-11-25 | MRVI | Buy (P) | +15,000 | $405.0K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.